{"meta":{"query_hash":"4c4dfa6dda92","filters":{"venue":"Global Cardiology"},"cohort_total":8,"direct_labels_cover":0,"predictions_cover":8,"exported":8,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4c4dfa6dda92","api":"https://metacan.xera.ac/api/v1/cohort?venue=Global+Cardiology"},"results":[{"id":"W4390758410","doi":"10.4081/globcardio.2023.2","title":"SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials","year":2023,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Empagliflozin; Dapagliflozin; Medicine; Hazard ratio; Internal medicine; Placebo; Randomized controlled trial; Meta-analysis; Confidence interval; Diabetes mellitus; Relative risk; Type 2 diabetes; Endocrinology","score_opus":0.044553951690806344,"score_gpt":0.33098623453234705,"score_spread":0.2864322828415407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390758410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929552,0.0013430063,0.00016830984,0.00011822888,0.00031723987,0.004087051,0.00057544577,0.000036000754,0.00039951337],"genre_scores_gemma":[0.9969938,0.0011139037,0.00012628335,0.00001964777,0.00007091973,0.0011316945,0.00044645314,0.0000053089802,0.00009201863],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99626,0.0019002933,0.0011446173,0.00031629903,0.0001736146,0.00020520765],"domain_scores_gemma":[0.99780643,0.0010858853,0.00068703806,0.0002324792,0.00013703393,0.000051121286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007681816,0.00017047471,0.009377347,0.00034478703,0.000027971675,0.000006413356,0.000034017125,0.00010548018,0.000015899765],"category_scores_gemma":[0.0044742473,0.00010140492,0.0037624654,0.0006267592,0.000108484724,0.000030100693,0.000037509886,0.000047229903,0.000002226753],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047659673,0.00007860951,0.30459464,0.000026377278,0.6438029,0.0000040186987,0.000030367293,0.00086392765,0.000004369653,0.0005277037,0.0011897868,0.0012176664],"study_design_scores_gemma":[0.23222043,0.00020622759,0.14378583,0.0000018240554,0.621872,1.7940418e-7,0.00004510143,0.00022935179,0.0000088758,0.0015075254,0.00006355271,0.000059111728],"about_ca_topic_score_codex":0.0007888463,"about_ca_topic_score_gemma":0.000059078415,"teacher_disagreement_score":0.18456075,"about_ca_system_score_codex":0.000058010275,"about_ca_system_score_gemma":0.00001676991,"threshold_uncertainty_score":0.6410167},"labels":[],"label_agreement":null},{"id":"W4390776745","doi":"10.4081/globalcard.2023.2","title":"SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials","year":2023,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Empagliflozin; Dapagliflozin; Medicine; Hazard ratio; Internal medicine; Placebo; Randomized controlled trial; Meta-analysis; Relative risk; Diabetes mellitus; Confidence interval; Type 2 diabetes; Endocrinology","score_opus":0.044553951690806344,"score_gpt":0.33098623453234705,"score_spread":0.2864322828415407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390776745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929552,0.0013430063,0.00016830984,0.00011822888,0.00031723987,0.004087051,0.00057544577,0.000036000754,0.00039951337],"genre_scores_gemma":[0.9969938,0.0011139037,0.00012628335,0.00001964777,0.00007091973,0.0011316945,0.00044645314,0.0000053089802,0.00009201863],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99626,0.0019002933,0.0011446173,0.00031629903,0.0001736146,0.00020520765],"domain_scores_gemma":[0.99780643,0.0010858853,0.00068703806,0.0002324792,0.00013703393,0.000051121286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007681816,0.00017047471,0.009377347,0.00034478703,0.000027971675,0.000006413356,0.000034017125,0.00010548018,0.000015899765],"category_scores_gemma":[0.0044742473,0.00010140492,0.0037624654,0.0006267592,0.000108484724,0.000030100693,0.000037509886,0.000047229903,0.000002226753],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047659673,0.00007860951,0.30459464,0.000026377278,0.6438029,0.0000040186987,0.000030367293,0.00086392765,0.000004369653,0.0005277037,0.0011897868,0.0012176664],"study_design_scores_gemma":[0.23222043,0.00020622759,0.14378583,0.0000018240554,0.621872,1.7940418e-7,0.00004510143,0.00022935179,0.0000088758,0.0015075254,0.00006355271,0.000059111728],"about_ca_topic_score_codex":0.0007888463,"about_ca_topic_score_gemma":0.000059078415,"teacher_disagreement_score":0.18456075,"about_ca_system_score_codex":0.000058010275,"about_ca_system_score_gemma":0.00001676991,"threshold_uncertainty_score":0.6410167},"labels":[],"label_agreement":null},{"id":"W4390816339","doi":"10.4081/cardio.2023.2","title":"SGLT2 inhibitors and risk reduction for mortality in high-risk patients: a meta-analysis of randomized controlled trials","year":2023,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Empagliflozin; Dapagliflozin; Medicine; Hazard ratio; Internal medicine; Placebo; Randomized controlled trial; Relative risk; Meta-analysis; Diabetes mellitus; Confidence interval; Type 2 diabetes; Endocrinology","score_opus":0.044553951690806344,"score_gpt":0.33098623453234705,"score_spread":0.2864322828415407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390816339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929552,0.0013430063,0.00016830984,0.00011822888,0.00031723987,0.004087051,0.00057544577,0.000036000754,0.00039951337],"genre_scores_gemma":[0.9969938,0.0011139037,0.00012628335,0.00001964777,0.00007091973,0.0011316945,0.00044645314,0.0000053089802,0.00009201863],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99626,0.0019002933,0.0011446173,0.00031629903,0.0001736146,0.00020520765],"domain_scores_gemma":[0.99780643,0.0010858853,0.00068703806,0.0002324792,0.00013703393,0.000051121286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007681816,0.00017047471,0.009377347,0.00034478703,0.000027971675,0.000006413356,0.000034017125,0.00010548018,0.000015899765],"category_scores_gemma":[0.0044742473,0.00010140492,0.0037624654,0.0006267592,0.000108484724,0.000030100693,0.000037509886,0.000047229903,0.000002226753],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047659673,0.00007860951,0.30459464,0.000026377278,0.6438029,0.0000040186987,0.000030367293,0.00086392765,0.000004369653,0.0005277037,0.0011897868,0.0012176664],"study_design_scores_gemma":[0.23222043,0.00020622759,0.14378583,0.0000018240554,0.621872,1.7940418e-7,0.00004510143,0.00022935179,0.0000088758,0.0015075254,0.00006355271,0.000059111728],"about_ca_topic_score_codex":0.0007888463,"about_ca_topic_score_gemma":0.000059078415,"teacher_disagreement_score":0.18456075,"about_ca_system_score_codex":0.000058010275,"about_ca_system_score_gemma":0.00001676991,"threshold_uncertainty_score":0.6410167},"labels":[],"label_agreement":null},{"id":"W4400213250","doi":"10.4081/cardio.2024.40","title":"Baseline echocardiographic characteristics of patients enrolled in the randomized investigation of MitraClip device in heart failure (RESHAPE HF-2) trial: comparison with COAPT and Mitra-FR","year":2024,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surgical Specialties (Canada); Health Care Foundation","funders":"Abbott Vascular; St. Jude Medical; Daiichi Sankyo Europe; Servier; Innosuisse - Schweizerische Agentur für Innovationsförderung; Vifor Pharma; Universität Zürich; CytoSorbents Europe; Deutsche Forschungsgemeinschaft; British Heart Foundation; Sanofi; Abiomed; Horizon Therapeutics; Pfizer; Moderna; MicroPort; Impulse Dynamics; Hamilton Health Sciences; Mundipharma Medical Company, Basel; Kiniksa Pharmaceuticals; Cytokinetics; Biosense Webster; Novo Nordisk; HeartWare; ZOLL Medical Corporation; Regeneron Pharmaceuticals; Boston Scientific Corporation; AstraZeneca; Amarin Corporation; Javna Agencija za Raziskovalno Dejavnost RS; Alexion Pharmaceuticals; Thoratec Corporation; Cardinal Health; Edwards Lifesciences; Amgen; Eli Lilly and Company; Bayer Vital; Bristol-Myers Squibb","keywords":"Medicine; Ejection fraction; MitraClip; Internal medicine; Cardiology; Heart failure; Randomized controlled trial; Mitral regurgitation","score_opus":0.01189000808189308,"score_gpt":0.30609408339499217,"score_spread":0.2942040753130991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400213250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364865,0.0035949722,0.000025898755,0.00031673012,0.00013394943,0.0017857229,0.00029052072,0.000014909952,0.00018863086],"genre_scores_gemma":[0.99904025,0.0001804816,0.0001226967,0.00013023226,0.000066705026,0.00011343506,0.000334953,0.000010171251,0.0000010817062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977469,0.0008929404,0.0006317656,0.0002828859,0.00025607058,0.00018948078],"domain_scores_gemma":[0.9989305,0.0005154872,0.00012817512,0.00022728501,0.00012619236,0.00007232288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009158691,0.00019002367,0.0016270338,0.00016479946,0.000016089798,0.000010184904,0.00005665926,0.00013368455,0.0000072002867],"category_scores_gemma":[0.0002680519,0.00011962419,0.00071157154,0.0005614455,0.00026389793,0.000037931288,0.000022435574,0.00015874556,0.0000019768586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10397814,0.00009706517,0.8936653,0.0001632676,0.0009519182,0.000031606207,0.00009868557,0.000016507247,0.000010809134,0.00008994543,0.00024198792,0.0006547583],"study_design_scores_gemma":[0.18485306,0.0004977361,0.81235087,0.00017672022,0.0013898178,0.000016090024,0.00011316151,0.000160817,0.000005682288,0.00012562069,0.00022784591,0.000082566185],"about_ca_topic_score_codex":0.00021086939,"about_ca_topic_score_gemma":0.000022617925,"teacher_disagreement_score":0.08131443,"about_ca_system_score_codex":0.000047567584,"about_ca_system_score_gemma":0.00010970492,"threshold_uncertainty_score":0.4878133},"labels":[],"label_agreement":null},{"id":"W4410048829","doi":"10.4081/cardio.2025.70","title":"iCARDIO Alliance Global Implementation Guidelines on Heart Failure 2025","year":2025,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Boniface Hospital; Population Health Research Institute; University of Alberta; University of Manitoba","funders":"National Taiwan University Hospital; Universität des Saarlandes; National Taiwan University; Heart Research Institute; McMaster University; Vanderbilt University","keywords":"Context (archaeology); Alliance; Risk analysis (engineering); Health care; Medicine; Population; Resource (disambiguation); Heart failure; Intensive care medicine; Business; Computer science; Political science","score_opus":0.03200285949723429,"score_gpt":0.3950073607025411,"score_spread":0.3630045012053068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410048829","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21704386,0.00465741,0.009087681,0.4808356,0.004453256,0.004600767,0.0005361111,0.00092413835,0.27786118],"genre_scores_gemma":[0.95625716,0.000251326,0.014620407,0.024321014,0.00093612244,0.00021507352,0.0004000572,0.000013887431,0.0029849336],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99843186,0.000099977995,0.00035994456,0.00046796197,0.00021717497,0.00042307904],"domain_scores_gemma":[0.9992092,0.000019833156,0.00004036848,0.00044070333,0.00018188563,0.000107996195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022267259,0.00023158606,0.00058111356,0.000035561836,0.00008583762,0.000018023564,0.00009714168,0.0001453831,0.00009374903],"category_scores_gemma":[0.00007490034,0.00019638975,0.00029340628,0.0003816329,0.00006072934,0.00004134168,0.0000931342,0.00008713271,0.00036548302],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012813466,0.000021826314,0.17269361,0.000024461866,0.00047433205,0.00006436975,0.0000020472548,0.000063375,0.000032154036,0.011058111,0.80337936,0.012058202],"study_design_scores_gemma":[0.0017252436,0.00027793684,0.17015782,0.000043378204,0.00028908162,0.000053974698,0.0001092706,0.000008322681,0.000050545503,0.0011466818,0.8260242,0.00011356237],"about_ca_topic_score_codex":0.00012114543,"about_ca_topic_score_gemma":0.00009278499,"teacher_disagreement_score":0.7392133,"about_ca_system_score_codex":0.00048839056,"about_ca_system_score_gemma":0.00016414125,"threshold_uncertainty_score":0.80085415},"labels":[],"label_agreement":null},{"id":"W4412471224","doi":"10.4081/cardio.2025.77","title":"Applicability of obesity clinical practice guidelines in low- and middle-income countries","year":2025,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Obesity; Medicine; Specialty; Disease; Family medicine; Clinical Practice; Developing country; Environmental health; Gerontology; Pathology; Economic growth","score_opus":0.13656596509784596,"score_gpt":0.5270420251768815,"score_spread":0.3904760600790355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412471224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9646057,0.0012285219,0.0027432428,0.02256585,0.00056411076,0.00073553744,0.000066435714,0.00003692173,0.0074537117],"genre_scores_gemma":[0.9805225,0.0007490029,0.0110199405,0.0074008647,0.00023000887,0.000019870642,0.000019972309,0.000004627292,0.00003319704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651116,0.0005097052,0.0021293515,0.00043542596,0.00019245506,0.00022192362],"domain_scores_gemma":[0.9949229,0.003063062,0.00033016474,0.0004452438,0.0011516174,0.00008701065],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004871823,0.00013652639,0.0008610019,0.000049763243,0.000028677548,0.0000066317066,0.00009784726,0.00025977648,0.000014122107],"category_scores_gemma":[0.051551517,0.00012345544,0.00014020408,0.00030347722,0.00038512278,0.00011420953,0.00020196928,0.00026752552,0.000011380714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001313348,0.00009485477,0.9875411,0.00033550916,0.00014007003,0.00004116588,0.0000068650215,0.000020009755,0.000005032746,0.002481732,0.0017454241,0.0062749297],"study_design_scores_gemma":[0.0027496107,0.00026569885,0.9589146,0.00020472307,0.00033639238,0.0001413538,0.00031893342,0.00013318472,0.000011043139,0.0028141125,0.03401868,0.00009170645],"about_ca_topic_score_codex":0.0005695105,"about_ca_topic_score_gemma":0.00015049729,"teacher_disagreement_score":0.046679694,"about_ca_system_score_codex":0.00013499359,"about_ca_system_score_gemma":0.0004046893,"threshold_uncertainty_score":0.95643765},"labels":[],"label_agreement":null},{"id":"W4413893866","doi":"10.4081/cardio.2025.80","title":"Lipoprotein(a): what clinicians need to know","year":2025,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Need to know; Medicine; Intensive care medicine; Computer science; Computer security","score_opus":0.011634917237357392,"score_gpt":0.3144226758901416,"score_spread":0.30278775865278423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413893866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49051675,0.053803083,0.028456362,0.084235065,0.010188563,0.006024554,0.00009024721,0.000774364,0.32591102],"genre_scores_gemma":[0.97514474,0.001612859,0.0013028808,0.018691098,0.0015087962,0.0001844609,0.000034733435,0.000018748666,0.0015016561],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808604,0.00020202424,0.0003759904,0.00051996205,0.00025901294,0.0005569615],"domain_scores_gemma":[0.9984962,0.000028781376,0.000039474213,0.00096561195,0.00019130108,0.00027866903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070038985,0.0002110462,0.0009397965,0.000099588775,0.000098101766,0.00003611075,0.00016871202,0.00030955215,0.000031177733],"category_scores_gemma":[0.00026834945,0.00018424254,0.00060476916,0.000644612,0.000082197155,0.00007384746,0.00015449332,0.00023626456,0.00035363698],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006900779,0.000066411034,0.016404906,0.00020205625,0.0011488032,0.00044263928,0.000044284523,0.00011873982,0.00021374346,0.0071095917,0.12616307,0.84739566],"study_design_scores_gemma":[0.0019309191,0.0005992181,0.07649563,0.00025481018,0.00035032752,0.00044458374,0.00055898185,0.000010779251,0.0002115726,0.0013697186,0.91754764,0.00022578354],"about_ca_topic_score_codex":0.00040752275,"about_ca_topic_score_gemma":0.000061533465,"teacher_disagreement_score":0.8471699,"about_ca_system_score_codex":0.0002969609,"about_ca_system_score_gemma":0.0003856137,"threshold_uncertainty_score":0.7513193},"labels":[],"label_agreement":null},{"id":"W7084034459","doi":"10.4081/cardio.2025.86","title":"iCARDIO Alliance Global Implementation Guidelines for the Management of Obesity 2025 - Focus on prevention and treatment of cardiometabolic disease","year":2025,"lang":"en","type":"article","venue":"Global Cardiology","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Institut universitaire de cardiologie et de pneumologie de Québec; St. Boniface Hospital","funders":"","keywords":"Health care; Alliance; Global health; Resource (disambiguation); MEDLINE; Disease management; Burden of disease","score_opus":0.03768081832754278,"score_gpt":0.392106304695882,"score_spread":0.3544254863683392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7084034459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90079933,0.027547052,0.05954639,0.0021710312,0.0008229225,0.0029379916,0.0021327278,0.0000132577325,0.004029301],"genre_scores_gemma":[0.9852805,0.012875929,0.0012403372,0.0000689971,0.00012811365,0.000112304624,0.00015522145,0.0000027970655,0.00013580617],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99900043,0.00006889887,0.00033532162,0.0002299516,0.00015731865,0.00020810179],"domain_scores_gemma":[0.99927366,0.000017834576,0.00008632696,0.000324404,0.0002347223,0.00006305781],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025803255,0.00012640483,0.00029331064,0.000018228768,0.00005523318,0.0000070819406,0.00015304312,0.00008067651,0.0000015188821],"category_scores_gemma":[0.000051529478,0.00008836154,0.00023464787,0.00013040964,0.00017486955,0.0000021762391,0.00011846311,0.00001524231,7.251407e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010697145,0.00012620735,0.08030939,0.0003570046,0.0030225778,0.0000031483155,0.000011333839,0.0003978231,0.00062997406,0.005935437,0.0077512604,0.90038615],"study_design_scores_gemma":[0.0042273165,0.0020938553,0.89202005,0.00006687332,0.0011051481,0.000004108364,0.00071702205,0.00019679753,0.005516369,0.0073215994,0.08649177,0.00023906448],"about_ca_topic_score_codex":0.000048141406,"about_ca_topic_score_gemma":0.00003289872,"teacher_disagreement_score":0.9001471,"about_ca_system_score_codex":0.00004959338,"about_ca_system_score_gemma":0.00009870389,"threshold_uncertainty_score":0.36032793},"labels":[],"label_agreement":null}]}